Clinical Trial Update: Protective Effect of Sivelestat Sodium on ARDS in Patients With Sepsis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether sivelestat sodium provides a protective effect in acute respiratory distress syndrome (ARDS) patients with sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• Sivelestat sodium (sivelestat sodium)

Snippet

Sponsor: Southeast University, China | Conditions: ARDS | Phase 3 | Status: UNKNOWN